162 related articles for article (PubMed ID: 21199010)
1. MicroRNA signatures associated with immortalization of EBV-transformed lymphoblastoid cell lines and their clinical traits.
Lee JE; Hong EJ; Nam HY; Kim JW; Han BG; Jeon JP
Cell Prolif; 2011 Feb; 44(1):59-66. PubMed ID: 21199010
[TBL] [Abstract][Full Text] [Related]
2. Expression phenotype changes of EBV-transformed lymphoblastoid cell lines during long-term subculture and its clinical significance.
Lee JE; Nam HY; Shim SM; Bae GR; Han BG; Jeon JP
Cell Prolif; 2010 Aug; 43(4):378-84. PubMed ID: 20590663
[TBL] [Abstract][Full Text] [Related]
3. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus.
Linnstaedt SD; Gottwein E; Skalsky RL; Luftig MA; Cullen BR
J Virol; 2010 Nov; 84(22):11670-8. PubMed ID: 20844043
[TBL] [Abstract][Full Text] [Related]
4. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Chen A; Zhao B; Kieff E; Aster JC; Wang F
J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
[TBL] [Abstract][Full Text] [Related]
5. Network signatures of cellular immortalization in human lymphoblastoid cell lines.
Shim SM; Jung SY; Nam HY; Kim HR; Lee MH; Kim JW; Han BG; Jeon JP
Biochem Biophys Res Commun; 2013 Nov; 441(2):438-46. PubMed ID: 24369900
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
7. The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene expression in cis.
Poling BC; Price AM; Luftig MA; Cullen BR
Virology; 2017 Dec; 512():113-123. PubMed ID: 28950226
[TBL] [Abstract][Full Text] [Related]
8. TAX1BP1 downregulation by EBV-miR-BART15-3p enhances chemosensitivity of gastric cancer cells to 5-FU.
Choi H; Lee SK
Arch Virol; 2017 Feb; 162(2):369-377. PubMed ID: 27757686
[TBL] [Abstract][Full Text] [Related]
9. CD19 signalling improves the Epstein-Barr virus-induced immortalization of human B cell.
Hur DY; Lee MH; Kim JW; Kim JH; Shin YK; Rho JK; Kwack KB; Lee WJ; Han BG
Cell Prolif; 2005 Feb; 38(1):35-45. PubMed ID: 15679865
[TBL] [Abstract][Full Text] [Related]
10. Molecular signatures in response to Isoliquiritigenin in lymphoblastoid cell lines.
Lee JE; Hong EJ; Nam HY; Hwang M; Kim JH; Han BG; Jeon JP
Biochem Biophys Res Commun; 2012 Oct; 427(2):392-7. PubMed ID: 22995316
[TBL] [Abstract][Full Text] [Related]
11. Copy number increase of 1p36.33 and mitochondrial genome amplification in Epstein-Barr virus-transformed lymphoblastoid cell lines.
Jeon JP; Shim SM; Nam HY; Baik SY; Kim JW; Han BG
Cancer Genet Cytogenet; 2007 Mar; 173(2):122-30. PubMed ID: 17321327
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
Shinden Y; Hirashima T; Nohata N; Toda H; Okada R; Asai S; Tanaka T; Hozaka Y; Ohtsuka T; Kijima Y; Seki N
J Hum Genet; 2021 May; 66(5):519-534. PubMed ID: 33177704
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in human lymphoblastoid cell lines.
Shim SM; Nam HY; Lee JE; Kim JW; Han BG; Jeon JP
Crit Rev Eukaryot Gene Expr; 2012; 22(3):189-96. PubMed ID: 23140160
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways.
Cameron JE; Yin Q; Fewell C; Lacey M; McBride J; Wang X; Lin Z; Schaefer BC; Flemington EK
J Virol; 2008 Feb; 82(4):1946-58. PubMed ID: 18057241
[TBL] [Abstract][Full Text] [Related]
15. microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma.
Imig J; Motsch N; Zhu JY; Barth S; Okoniewski M; Reineke T; Tinguely M; Faggioni A; Trivedi P; Meister G; Renner C; Grässer FA
Nucleic Acids Res; 2011 Mar; 39(5):1880-93. PubMed ID: 21062812
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression.
Wang L; Toomey NL; Diaz LA; Walker G; Ramos JC; Barber GN; Ning S
J Virol; 2011 Aug; 85(16):8328-37. PubMed ID: 21680528
[TBL] [Abstract][Full Text] [Related]
17. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
Sugimoto M; Tahara H; Ide T; Furuichi Y
Cancer Res; 2004 May; 64(10):3361-4. PubMed ID: 15150084
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines before and after immortalization.
Toda T; Sugimoto M; Omori A; Matsuzaki T; Furuichi Y; Kimura N
Electrophoresis; 2000 May; 21(9):1814-22. PubMed ID: 10870967
[TBL] [Abstract][Full Text] [Related]
19. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
[TBL] [Abstract][Full Text] [Related]
20. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
Faumont N; Durand-Panteix S; Schlee M; Grömminger S; Schuhmacher M; Hölzel M; Laux G; Mailhammer R; Rosenwald A; Staudt LM; Bornkamm GW; Feuillard J
J Virol; 2009 May; 83(10):5014-27. PubMed ID: 19264782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
